Safety and Efficacy of Ianalumab in Patients With Sjögren's Disease: 52‐Week Results From a Randomized, Placebo‐Controlled, Phase 2b Dose‐Ranging Study

In patients with SjD, ianalumab 300 mg demonstrated sustained efficacy through week 52 and a favorable safety profile up to two years of follow-up.

Authors

Institutions

Publication Details

Journal
Arthritis & Rheumatology
Published
2024-11-18
DOI
https://doi.org/10.1002/art.43059
Citations
9
Primary Topic
Salivary Gland Disorders and Functions
Type
article
Field-Weighted Citation Impact
2.94
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Safety and Efficacy of Ianalumab in Patients With Sjögren's Disease: 52‐Week Results From a Randomized, Placebo‐Controlled, Phase 2b Dose‐Ranging Study

Benjamin A. Fisher, Wolfgang Hueber, Salvatore De Vita, Thomas Grader‐Beck et al.
9 citations
Arthritis & Rheumatology
Salivary Gland Disorders and Functions
2.94
article

Safety and Efficacy of Ianalumab in Patients With Sjögren's Disease: 52‐Week Results From a Randomized, Placebo‐Controlled, Phase 2b Dose‐Ranging Study

Benjamin A. Fisher, Wolfgang Hueber, Salvatore De Vita, Thomas Grader‐Beck, Robert I. Fox, Filipe Barcelos, Monika Sopala, Simon Bowman, G. Junge, Xavier Mariette, Wen‐Lin Luo, Alexandre Avraméas, J. Woznicki, Robert J. Moots, Hendrik Schulze‐Koops, Thomas Dörner, Athena Papas
article en
9 citations

Abstract

In patients with SjD, ianalumab 300 mg demonstrated sustained efficacy through week 52 and a favorable safety profile up to two years of follow-up.

Arthritis & RheumatologyVol. 77(5)
Tufts University (US), Novartis (Switzerland) (CH), University of Udine (IT), University Hospitals Birmingham NHS Foundation Trust (GB), Johns Hopkins University (US), University of Liverpool (GB), Edge Hill University (GB), Université Paris-Saclay (FR), Aintree University Hospital (GB), Scripps Memorial Hospital (US), Novartis (United States) (US), Instituto Português de Malacologia (PT), Bicêtre Hospital (FR), NIHR Birmingham Biomedical Research Centre (GB), Instituto Português de Reumatologia, Charité - Universitätsmedizin Berlin (DE), University of Birmingham (GB), Ludwig-Maximilians-Universität München (DE)
Good health and well-being
Openalex Percentile: Top 8%
Salivary Gland Disorders and Functions
2.94
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.